Neuroendocrine Cancer | Tumor

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

Writing a Book Helped a Survivor Process Fears of Cancer Recurrence

November 10th 2022, 4:00pm

Podcast

A woman with a rare and aggressive cancer shares how writing about the realities of cancer survivorship improved her mental health and even helped strengthen her relationship with her family.

FDA OKs Clinical Trial for Novel Neuroendocrine Carcinoma Drug

November 10th 2022, 2:00pm

Article

A phase 2 clinical trial will evaluate iadademstat for patients with relapsed or refractory high-grade neuroendocrine carcinoma.

Clinical Trial Kicks Off Evaluating a New Drug for a Group of Solid Cancers

November 4th 2022, 7:00pm

Article

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

FDA to Fast Track Development, Review of Novel Radiotherapy Drug for Neuroendocrine Tumors

October 28th 2022, 9:00pm

Article

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.

Do You Ever Question Your Cancer Care?

May 23rd 2022, 5:00pm

Article

I’ve always received impeccable care at my cancer center, but a recent experience made me feel like I was no longer a priority.

During the Pre-Cancer Days, My Intuition Pushed Me in the Right Direction

April 27th 2022, 5:00pm

Article

Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022, 3:02pm

Article

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.

3 Stages of Coping With Cancer: There Are Better Days Ahead

March 3rd 2022, 6:00pm

Article

When I was first diagnosed with a stage 4 neuroendocrine tumor in my small intestine, I went through three stages of coping with my cancer: anger, planning and living life.

Trial Underway to Assess Efficacy of Novel Radiopharmaceutical Drug in Neuroendocrine Tumors

January 5th 2022, 10:00pm

Article

The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies

December 13th 2021, 4:00pm

Article

For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to an expert.